DE69734709D1 - Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden - Google Patents
Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroidenInfo
- Publication number
- DE69734709D1 DE69734709D1 DE69734709T DE69734709T DE69734709D1 DE 69734709 D1 DE69734709 D1 DE 69734709D1 DE 69734709 T DE69734709 T DE 69734709T DE 69734709 T DE69734709 T DE 69734709T DE 69734709 D1 DE69734709 D1 DE 69734709D1
- Authority
- DE
- Germany
- Prior art keywords
- drug
- carboxyl group
- group
- spacer
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 150000003431 steroids Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 11
- 229940079593 drug Drugs 0.000 abstract 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 7
- 125000006850 spacer group Chemical group 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000003277 amino group Chemical group 0.000 abstract 2
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11525796 | 1996-04-15 | ||
JP32588096 | 1996-11-22 | ||
PCT/JP1997/001303 WO1997038727A1 (fr) | 1996-04-15 | 1997-04-15 | Composite medicamenteux |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69734709D1 true DE69734709D1 (de) | 2005-12-29 |
Family
ID=26453799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69734709T Expired - Lifetime DE69734709D1 (de) | 1996-04-15 | 1997-04-15 | Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden |
Country Status (7)
Country | Link |
---|---|
US (1) | US6458347B1 (de) |
EP (1) | EP0895784B1 (de) |
JP (2) | JP4420472B2 (de) |
AT (1) | ATE310538T1 (de) |
CA (1) | CA2251742C (de) |
DE (1) | DE69734709D1 (de) |
WO (1) | WO1997038727A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997038727A1 (fr) * | 1996-04-15 | 1997-10-23 | Asahi Kasei Kogyo Kabushiki Kaisha | Composite medicamenteux |
US6541508B2 (en) | 1999-09-13 | 2003-04-01 | Nobex Corporation | Taxane prodrugs |
US6380405B1 (en) | 1999-09-13 | 2002-04-30 | Nobex Corporation | Taxane prodrugs |
US6713454B1 (en) | 1999-09-13 | 2004-03-30 | Nobex Corporation | Prodrugs of etoposide and etoposide analogs |
DK1407784T3 (da) * | 2001-06-25 | 2011-02-28 | Ajinomoto Kk | Antitumormidler |
TWI313609B (en) * | 2001-08-21 | 2009-08-21 | Mitsubishi Tanabe Pharma Corp | Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor |
DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
DE10324710A1 (de) | 2003-05-30 | 2004-12-16 | Supramol Parenteral Colloids Gmbh | Stärkederivatkomplexe |
WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
US7282590B2 (en) * | 2004-02-12 | 2007-10-16 | The Research Foundation Of State University Of New York | Drug conjugates |
EP1792927B1 (de) * | 2004-09-22 | 2013-03-06 | Nippon Kayaku Kabushiki Kaisha | Neues blockcopolymer, micellenzubereitung und antikrebsmittel, das diese als wirkbestandteil enthält |
US9603941B2 (en) * | 2006-01-24 | 2017-03-28 | Minghui Chai | Method of preparing dendritic drugs |
US8323669B2 (en) | 2006-03-28 | 2012-12-04 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of taxane |
WO2007135910A1 (ja) | 2006-05-18 | 2007-11-29 | Nippon Kayaku Kabushiki Kaisha | ポドフィロトキシン類の高分子結合体 |
US20080108138A1 (en) * | 2006-06-13 | 2008-05-08 | Vermette Patrick | Bioactive compositions and their use in cell patterning |
US20090239782A1 (en) * | 2006-10-03 | 2009-09-24 | Masaharu Nakamura | High-molecular weight conjugate of resorcinol derivatives |
JP5503872B2 (ja) | 2006-11-06 | 2014-05-28 | 日本化薬株式会社 | 核酸系代謝拮抗剤の高分子誘導体 |
WO2008056654A1 (en) | 2006-11-08 | 2008-05-15 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
US8703878B2 (en) * | 2007-09-28 | 2014-04-22 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of steroids |
US8920788B2 (en) | 2008-03-18 | 2014-12-30 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of physiologically active substances |
US9149540B2 (en) | 2008-05-08 | 2015-10-06 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of folic acid or folic acid derivative |
US8808749B2 (en) | 2009-05-15 | 2014-08-19 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of bioactive substance having hydroxy group |
CN103221054A (zh) | 2010-11-17 | 2013-07-24 | 日本化药株式会社 | 新的胞苷类代谢拮抗剂的高分子衍生物 |
PT2754682T (pt) | 2011-09-11 | 2017-08-29 | Nippon Kayaku Kk | Método para o fabrico de copolímero de bloco |
WO2015005458A1 (ja) * | 2013-07-10 | 2015-01-15 | 生化学工業株式会社 | グリコサミノグリカン誘導体及びその製造方法 |
US10675354B2 (en) | 2013-07-10 | 2020-06-09 | Seikagaku Corporation | Glycosaminoglycan derivative and method for producing same |
WO2015071841A1 (en) | 2013-11-12 | 2015-05-21 | Druggability Technologies Holdings Limited | Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6067503A (ja) * | 1983-09-24 | 1985-04-17 | Kyowa Hakko Kogyo Co Ltd | マイトマイシン類と多糖類との結合体 |
GB8500209D0 (en) | 1985-01-04 | 1985-02-13 | Ceskoslovenska Akademie Ved | Synthetic polymeric drugs |
WO1993024476A1 (en) * | 1992-06-04 | 1993-12-09 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
GB9213077D0 (en) | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
DE4236237A1 (de) | 1992-10-27 | 1994-04-28 | Behringwerke Ag | Prodrugs, ihre Herstellung und Verwendung als Arzneimittel |
US5646176A (en) | 1992-12-24 | 1997-07-08 | Bristol-Myers Squibb Company | Phosphonooxymethyl ethers of taxane derivatives |
DK0640622T3 (da) | 1993-02-26 | 2000-10-23 | Drug Delivery System Inst Ltd | Polysaccharidderivat og lægemiddelbærer |
US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
EP0727992A4 (de) | 1993-10-20 | 2001-01-31 | Enzon Inc | 2'-und/oder 7-substituierte taxoide |
US5760072A (en) * | 1995-12-29 | 1998-06-02 | Pharmachemie B.V. | Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
KR100561788B1 (ko) * | 1996-03-12 | 2006-09-20 | 피지-티엑스엘 컴파니,엘.피. | 수용성파클리탁셀전구약물을포함하는조성물및이러한조성물을포함하는이식가능한의료장치 |
WO1997038727A1 (fr) * | 1996-04-15 | 1997-10-23 | Asahi Kasei Kogyo Kabushiki Kaisha | Composite medicamenteux |
-
1997
- 1997-04-15 WO PCT/JP1997/001303 patent/WO1997038727A1/ja active IP Right Grant
- 1997-04-15 EP EP97915728A patent/EP0895784B1/de not_active Expired - Lifetime
- 1997-04-15 JP JP53695197A patent/JP4420472B2/ja not_active Expired - Fee Related
- 1997-04-15 CA CA002251742A patent/CA2251742C/en not_active Expired - Fee Related
- 1997-04-15 AT AT97915728T patent/ATE310538T1/de not_active IP Right Cessation
- 1997-04-15 DE DE69734709T patent/DE69734709D1/de not_active Expired - Lifetime
-
1998
- 1998-10-14 US US09/172,085 patent/US6458347B1/en not_active Expired - Lifetime
-
2009
- 2009-09-08 JP JP2009206567A patent/JP2009287036A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2251742C (en) | 2001-12-11 |
WO1997038727A1 (fr) | 1997-10-23 |
CA2251742A1 (en) | 1997-10-23 |
JP4420472B2 (ja) | 2010-02-24 |
EP0895784A1 (de) | 1999-02-10 |
EP0895784A4 (de) | 2003-03-19 |
EP0895784B1 (de) | 2005-11-23 |
ATE310538T1 (de) | 2005-12-15 |
US6458347B1 (en) | 2002-10-01 |
JP2009287036A (ja) | 2009-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69734709D1 (de) | Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden | |
GB9309324D0 (en) | Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives | |
ES2158537T3 (es) | Derivados de acidos ciclopropilalcanoicos. | |
BR0013949A (pt) | Prodroga de taxano, composição farmacêutica, e, método de tratamento de um paciente mamìfero | |
CA2057099A1 (en) | Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals | |
WO1996030010A3 (fr) | Utilisation du fumagillol et ses derives pour preparer les medicaments destines a combattre les infections intestinales | |
EP1213285A3 (de) | 4,5-Diphenyloxazolderivate und ihre Verendung als Blutplättchenaggregations-Inhibitoren | |
CA2150287A1 (en) | Agent for treating hepato-biliary diseases | |
KR950014073A (ko) | 이소퀴놀린 | |
IE821846L (en) | Carbamimidoyl-1-carbadethiapen-2-em-3 carboxylic acid | |
AU5504694A (en) | Substituted amic acid derivatives | |
DE3462039D1 (en) | Peptide derivatives, their preparation and use as elastase inhibitors | |
IL90056A (en) | Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives | |
NZ223287A (en) | 4-thiazolidine carboxylic acid derivatives and pharmaceutical compositions | |
AU4452693A (en) | Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method ofuse thereof | |
EP0806421A4 (de) | Derivate der chinolincarbonsäure | |
WO1989005580A1 (en) | Improvements in or relating to avian control | |
ES2103161A1 (es) | Derivados de cicloheptimidazol, metodo de fabricacion de los mismos y agentes terapeuticos que contienen estos compuestos. | |
EP0316712A3 (de) | 22-Dechloroteicoplanine | |
AU3929789A (en) | New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates | |
ES8802508A1 (es) | Procedimiento para preparar derivados alquenicos. | |
TW427998B (en) | Steroid esters, process for their production and their pharmaceutical use | |
FR2701944B1 (fr) | Procédé d'hydroxycarbonylation de lactones en acides dicarboxyliques aliphatiques. | |
WO1987004435A3 (en) | Xanthine compounds | |
AU5883790A (en) | Compounds from biopolymrs and effector substances which are linked via optically active amino acid derivatives, processes for the preparation thereof and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |